seed
Stage
1
Investors
About
Signatur Biosciences develops molecular diagnostic kits that translate complex RNA signatures into single qPCR assays compatible with standard qPCR machines, enabling decentralized and faster precision diagnostics for diseases including breast cancer prognosis.
Explore Signatur Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.